While the functional effect of the bacteria in CRC is still not well known, the Anaeroplasma genus was suggested to be a potential probiotic in treating intestinal inflammation and strengthening mucosal immune response by elevating IgA and TGF-β levels [60,61]. Here, TGFB1 is linked to colorectal carcinoma.